[
  {
    "id": "31cdae15-2c33-4d5c-8613-140b59200055",
    "topicId": null,
    "title": "62-Year-Old Woman with ER+/HER2- Breast Cancer",
    "description": "Post-menopausal woman with T2N1M0 invasive ductal carcinoma",
    "patientPresentation": {
      "age": 62,
      "gender": "Female",
      "stage": "T2N1M0",
      "histology": "Invasive ductal carcinoma",
      "receptors": "ER 95%, PR 85%, HER2 0, Ki-67 25%",
      "comorbidities": [
        "Hypertension",
        "Type 2 diabetes"
      ],
      "performance_status": "ECOG 0"
    },
    "decisionPoints": {
      "options1": [
        "Start chemotherapy immediately",
        "Order Oncotype DX testing",
        "Begin hormone therapy",
        "Refer for radiation therapy"
      ],
      "options2": [
        "Hormone therapy alone",
        "Chemotherapy then hormone therapy",
        "Neoadjuvant chemotherapy",
        "Clinical trial"
      ],
      "question1": "What is the most appropriate next step for treatment planning?",
      "question2": "If Oncotype DX recurrence score is 18, what is the recommended treatment?"
    },
    "correctPathway": [
      "Order Oncotype DX multigene assay (NCCN Category 1)",
      "Intermediate recurrence score (11-25) warrants multidisciplinary discussion",
      "Consider patient preferences and comorbidities",
      "Adjuvant hormone therapy with aromatase inhibitor for 5-10 years"
    ],
    "learningOutcomes": [
      "Appropriate use of multigene assays in hormone receptor-positive breast cancer",
      "Integration of patient factors in treatment decision-making",
      "Evidence-based hormone therapy duration recommendations"
    ],
    "guidelineReference": "NCCN Breast Cancer Guidelines V4.2025",
    "difficulty": "Fellow",
    "estimatedTime": 15,
    "tags": [
      "Breast Cancer",
      "Biomarkers",
      "Treatment Planning"
    ],
    "createdAt": "2025-06-30T13:54:42.432Z",
    "isActive": true
  },
  {
    "id": "7915bb26-e5e5-48c6-b21c-10ea53ddfcb0",
    "topicId": null,
    "title": "58-Year-Old Male with Extensive-Stage Small Cell Lung Cancer",
    "description": "Heavy smoker presenting with cough, weight loss, and multiple liver metastases",
    "patientPresentation": {
      "age": 58,
      "gender": "Male",
      "stage": "T3N2M1 (liver, adrenal)",
      "histology": "Small cell lung cancer",
      "smoking_history": "40 pack-years, current smoker",
      "symptoms": [
        "Persistent cough",
        "15 lb weight loss",
        "Fatigue"
      ],
      "performance_status": "ECOG 1",
      "labs": "Normal LDH, sodium 132 mEq/L"
    },
    "decisionPoints": {
      "options1": [
        "Carboplatin/Etoposide alone",
        "Cisplatin/Etoposide + Atezolizumab",
        "Carboplatin/Etoposide + Atezolizumab",
        "Topotecan monotherapy"
      ],
      "options2": [
        "Ignore if asymptomatic",
        "Check urine osmolality for SIADH",
        "Start immediate sodium replacement",
        "Delay treatment"
      ],
      "question1": "What is the most appropriate first-line treatment regimen?",
      "question2": "How should hyponatremia be evaluated in this patient?"
    },
    "correctPathway": [
      "Carboplatin/Etoposide + Atezolizumab first-line (NCCN Category 1)",
      "Evaluate and treat SIADH if present (common in SCLC)",
      "Continue atezolizumab maintenance after 4 cycles of chemotherapy",
      "Consider prophylactic cranial irradiation after response assessment"
    ],
    "learningOutcomes": [
      "Evidence-based immunotherapy integration in extensive-stage SCLC",
      "Recognition and management of SCLC paraneoplastic syndromes",
      "Appropriate use of maintenance immunotherapy"
    ],
    "guidelineReference": "NCCN Small Cell Lung Cancer Guidelines V4.2025",
    "difficulty": "Resident",
    "estimatedTime": 20,
    "tags": [
      "Lung Cancer",
      "Immunotherapy",
      "Paraneoplastic Syndromes"
    ],
    "createdAt": "2025-06-30T13:54:42.517Z",
    "isActive": true
  },
  {
    "id": "85dc3565-168d-45bb-ad8a-2ba3df176984",
    "topicId": null,
    "title": "62-Year-Old Woman with ER+/HER2- Breast Cancer",
    "description": "Post-menopausal woman with T2N1M0 invasive ductal carcinoma",
    "patientPresentation": {
      "age": 62,
      "gender": "Female",
      "stage": "T2N1M0",
      "histology": "Invasive ductal carcinoma",
      "receptors": "ER 95%, PR 85%, HER2 0, Ki-67 25%",
      "comorbidities": [
        "Hypertension",
        "Type 2 diabetes"
      ],
      "performance_status": "ECOG 0"
    },
    "decisionPoints": {
      "options1": [
        "Start chemotherapy immediately",
        "Order Oncotype DX testing",
        "Begin hormone therapy",
        "Refer for radiation therapy"
      ],
      "options2": [
        "Hormone therapy alone",
        "Chemotherapy then hormone therapy",
        "Neoadjuvant chemotherapy",
        "Clinical trial"
      ],
      "question1": "What is the most appropriate next step for treatment planning?",
      "question2": "If Oncotype DX recurrence score is 18, what is the recommended treatment?"
    },
    "correctPathway": [
      "Order Oncotype DX multigene assay (NCCN Category 1)",
      "Intermediate recurrence score (11-25) warrants multidisciplinary discussion",
      "Consider patient preferences and comorbidities",
      "Adjuvant hormone therapy with aromatase inhibitor for 5-10 years"
    ],
    "learningOutcomes": [
      "Appropriate use of multigene assays in hormone receptor-positive breast cancer",
      "Integration of patient factors in treatment decision-making",
      "Evidence-based hormone therapy duration recommendations"
    ],
    "guidelineReference": "NCCN Breast Cancer Guidelines V4.2025",
    "difficulty": "Fellow",
    "estimatedTime": 15,
    "tags": [
      "Breast Cancer",
      "Biomarkers",
      "Treatment Planning"
    ],
    "createdAt": "2025-06-30T13:54:55.921Z",
    "isActive": true
  },
  {
    "id": "d515ed95-688b-4208-bce5-8aa9516d7cd0",
    "topicId": null,
    "title": "58-Year-Old Male with Extensive-Stage Small Cell Lung Cancer",
    "description": "Heavy smoker presenting with cough, weight loss, and multiple liver metastases",
    "patientPresentation": {
      "age": 58,
      "gender": "Male",
      "stage": "T3N2M1 (liver, adrenal)",
      "histology": "Small cell lung cancer",
      "smoking_history": "40 pack-years, current smoker",
      "symptoms": [
        "Persistent cough",
        "15 lb weight loss",
        "Fatigue"
      ],
      "performance_status": "ECOG 1",
      "labs": "Normal LDH, sodium 132 mEq/L"
    },
    "decisionPoints": {
      "options1": [
        "Carboplatin/Etoposide alone",
        "Cisplatin/Etoposide + Atezolizumab",
        "Carboplatin/Etoposide + Atezolizumab",
        "Topotecan monotherapy"
      ],
      "options2": [
        "Ignore if asymptomatic",
        "Check urine osmolality for SIADH",
        "Start immediate sodium replacement",
        "Delay treatment"
      ],
      "question1": "What is the most appropriate first-line treatment regimen?",
      "question2": "How should hyponatremia be evaluated in this patient?"
    },
    "correctPathway": [
      "Carboplatin/Etoposide + Atezolizumab first-line (NCCN Category 1)",
      "Evaluate and treat SIADH if present (common in SCLC)",
      "Continue atezolizumab maintenance after 4 cycles of chemotherapy",
      "Consider prophylactic cranial irradiation after response assessment"
    ],
    "learningOutcomes": [
      "Evidence-based immunotherapy integration in extensive-stage SCLC",
      "Recognition and management of SCLC paraneoplastic syndromes",
      "Appropriate use of maintenance immunotherapy"
    ],
    "guidelineReference": "NCCN Small Cell Lung Cancer Guidelines V4.2025",
    "difficulty": "Resident",
    "estimatedTime": 20,
    "tags": [
      "Lung Cancer",
      "Immunotherapy",
      "Paraneoplastic Syndromes"
    ],
    "createdAt": "2025-06-30T13:54:56.008Z",
    "isActive": true
  },
  {
    "id": "b0e8197c-538f-4d4d-8127-1152e4a0c948",
    "topicId": null,
    "title": "62-Year-Old Woman with ER+/HER2- Breast Cancer",
    "description": "Post-menopausal woman with T2N1M0 invasive ductal carcinoma",
    "patientPresentation": {
      "age": 62,
      "gender": "Female",
      "stage": "T2N1M0",
      "histology": "Invasive ductal carcinoma",
      "receptors": "ER 95%, PR 85%, HER2 0, Ki-67 25%",
      "comorbidities": [
        "Hypertension",
        "Type 2 diabetes"
      ],
      "performance_status": "ECOG 0"
    },
    "decisionPoints": {
      "options1": [
        "Start chemotherapy immediately",
        "Order Oncotype DX testing",
        "Begin hormone therapy",
        "Refer for radiation therapy"
      ],
      "options2": [
        "Hormone therapy alone",
        "Chemotherapy then hormone therapy",
        "Neoadjuvant chemotherapy",
        "Clinical trial"
      ],
      "question1": "What is the most appropriate next step for treatment planning?",
      "question2": "If Oncotype DX recurrence score is 18, what is the recommended treatment?"
    },
    "correctPathway": [
      "Order Oncotype DX multigene assay (NCCN Category 1)",
      "Intermediate recurrence score (11-25) warrants multidisciplinary discussion",
      "Consider patient preferences and comorbidities",
      "Adjuvant hormone therapy with aromatase inhibitor for 5-10 years"
    ],
    "learningOutcomes": [
      "Appropriate use of multigene assays in hormone receptor-positive breast cancer",
      "Integration of patient factors in treatment decision-making",
      "Evidence-based hormone therapy duration recommendations"
    ],
    "guidelineReference": "NCCN Breast Cancer Guidelines V4.2025",
    "difficulty": "Fellow",
    "estimatedTime": 15,
    "tags": [
      "Breast Cancer",
      "Biomarkers",
      "Treatment Planning"
    ],
    "createdAt": "2025-06-30T13:55:07.028Z",
    "isActive": true
  },
  {
    "id": "747b7e35-cacd-4149-986b-13be4226321a",
    "topicId": null,
    "title": "58-Year-Old Male with Extensive-Stage Small Cell Lung Cancer",
    "description": "Heavy smoker presenting with cough, weight loss, and multiple liver metastases",
    "patientPresentation": {
      "age": 58,
      "gender": "Male",
      "stage": "T3N2M1 (liver, adrenal)",
      "histology": "Small cell lung cancer",
      "smoking_history": "40 pack-years, current smoker",
      "symptoms": [
        "Persistent cough",
        "15 lb weight loss",
        "Fatigue"
      ],
      "performance_status": "ECOG 1",
      "labs": "Normal LDH, sodium 132 mEq/L"
    },
    "decisionPoints": {
      "options1": [
        "Carboplatin/Etoposide alone",
        "Cisplatin/Etoposide + Atezolizumab",
        "Carboplatin/Etoposide + Atezolizumab",
        "Topotecan monotherapy"
      ],
      "options2": [
        "Ignore if asymptomatic",
        "Check urine osmolality for SIADH",
        "Start immediate sodium replacement",
        "Delay treatment"
      ],
      "question1": "What is the most appropriate first-line treatment regimen?",
      "question2": "How should hyponatremia be evaluated in this patient?"
    },
    "correctPathway": [
      "Carboplatin/Etoposide + Atezolizumab first-line (NCCN Category 1)",
      "Evaluate and treat SIADH if present (common in SCLC)",
      "Continue atezolizumab maintenance after 4 cycles of chemotherapy",
      "Consider prophylactic cranial irradiation after response assessment"
    ],
    "learningOutcomes": [
      "Evidence-based immunotherapy integration in extensive-stage SCLC",
      "Recognition and management of SCLC paraneoplastic syndromes",
      "Appropriate use of maintenance immunotherapy"
    ],
    "guidelineReference": "NCCN Small Cell Lung Cancer Guidelines V4.2025",
    "difficulty": "Resident",
    "estimatedTime": 20,
    "tags": [
      "Lung Cancer",
      "Immunotherapy",
      "Paraneoplastic Syndromes"
    ],
    "createdAt": "2025-06-30T13:55:07.110Z",
    "isActive": true
  },
  {
    "id": "b4801d67-8b79-4747-95c5-608765809e8d",
    "topicId": null,
    "title": "62-Year-Old Woman with ER+/HER2- Breast Cancer",
    "description": "Post-menopausal woman with T2N1M0 invasive ductal carcinoma",
    "patientPresentation": {
      "age": 62,
      "gender": "Female",
      "stage": "T2N1M0",
      "histology": "Invasive ductal carcinoma",
      "receptors": "ER 95%, PR 85%, HER2 0, Ki-67 25%",
      "comorbidities": [
        "Hypertension",
        "Type 2 diabetes"
      ],
      "performance_status": "ECOG 0"
    },
    "decisionPoints": {
      "options1": [
        "Start chemotherapy immediately",
        "Order Oncotype DX testing",
        "Begin hormone therapy",
        "Refer for radiation therapy"
      ],
      "options2": [
        "Hormone therapy alone",
        "Chemotherapy then hormone therapy",
        "Neoadjuvant chemotherapy",
        "Clinical trial"
      ],
      "question1": "What is the most appropriate next step for treatment planning?",
      "question2": "If Oncotype DX recurrence score is 18, what is the recommended treatment?"
    },
    "correctPathway": [
      "Order Oncotype DX multigene assay (NCCN Category 1)",
      "Intermediate recurrence score (11-25) warrants multidisciplinary discussion",
      "Consider patient preferences and comorbidities",
      "Adjuvant hormone therapy with aromatase inhibitor for 5-10 years"
    ],
    "learningOutcomes": [
      "Appropriate use of multigene assays in hormone receptor-positive breast cancer",
      "Integration of patient factors in treatment decision-making",
      "Evidence-based hormone therapy duration recommendations"
    ],
    "guidelineReference": "NCCN Breast Cancer Guidelines V4.2025",
    "difficulty": "Fellow",
    "estimatedTime": 15,
    "tags": [
      "Breast Cancer",
      "Biomarkers",
      "Treatment Planning"
    ],
    "createdAt": "2025-06-30T13:55:30.987Z",
    "isActive": true
  },
  {
    "id": "33f28bce-8af2-4bbd-ad36-17ad5fa69310",
    "topicId": null,
    "title": "58-Year-Old Male with Extensive-Stage Small Cell Lung Cancer",
    "description": "Heavy smoker presenting with cough, weight loss, and multiple liver metastases",
    "patientPresentation": {
      "age": 58,
      "gender": "Male",
      "stage": "T3N2M1 (liver, adrenal)",
      "histology": "Small cell lung cancer",
      "smoking_history": "40 pack-years, current smoker",
      "symptoms": [
        "Persistent cough",
        "15 lb weight loss",
        "Fatigue"
      ],
      "performance_status": "ECOG 1",
      "labs": "Normal LDH, sodium 132 mEq/L"
    },
    "decisionPoints": {
      "options1": [
        "Carboplatin/Etoposide alone",
        "Cisplatin/Etoposide + Atezolizumab",
        "Carboplatin/Etoposide + Atezolizumab",
        "Topotecan monotherapy"
      ],
      "options2": [
        "Ignore if asymptomatic",
        "Check urine osmolality for SIADH",
        "Start immediate sodium replacement",
        "Delay treatment"
      ],
      "question1": "What is the most appropriate first-line treatment regimen?",
      "question2": "How should hyponatremia be evaluated in this patient?"
    },
    "correctPathway": [
      "Carboplatin/Etoposide + Atezolizumab first-line (NCCN Category 1)",
      "Evaluate and treat SIADH if present (common in SCLC)",
      "Continue atezolizumab maintenance after 4 cycles of chemotherapy",
      "Consider prophylactic cranial irradiation after response assessment"
    ],
    "learningOutcomes": [
      "Evidence-based immunotherapy integration in extensive-stage SCLC",
      "Recognition and management of SCLC paraneoplastic syndromes",
      "Appropriate use of maintenance immunotherapy"
    ],
    "guidelineReference": "NCCN Small Cell Lung Cancer Guidelines V4.2025",
    "difficulty": "Resident",
    "estimatedTime": 20,
    "tags": [
      "Lung Cancer",
      "Immunotherapy",
      "Paraneoplastic Syndromes"
    ],
    "createdAt": "2025-06-30T13:55:31.062Z",
    "isActive": true
  },
  {
    "id": "0d0459d0-eacc-4689-ab9b-ebc5e586bb75",
    "topicId": null,
    "title": "62-Year-Old Woman with ER+/HER2- Breast Cancer",
    "description": "Post-menopausal woman with T2N1M0 invasive ductal carcinoma",
    "patientPresentation": {
      "age": 62,
      "gender": "Female",
      "stage": "T2N1M0",
      "histology": "Invasive ductal carcinoma",
      "receptors": "ER 95%, PR 85%, HER2 0, Ki-67 25%",
      "comorbidities": [
        "Hypertension",
        "Type 2 diabetes"
      ],
      "performance_status": "ECOG 0"
    },
    "decisionPoints": {
      "options1": [
        "Start chemotherapy immediately",
        "Order Oncotype DX testing",
        "Begin hormone therapy",
        "Refer for radiation therapy"
      ],
      "options2": [
        "Hormone therapy alone",
        "Chemotherapy then hormone therapy",
        "Neoadjuvant chemotherapy",
        "Clinical trial"
      ],
      "question1": "What is the most appropriate next step for treatment planning?",
      "question2": "If Oncotype DX recurrence score is 18, what is the recommended treatment?"
    },
    "correctPathway": [
      "Order Oncotype DX multigene assay (NCCN Category 1)",
      "Intermediate recurrence score (11-25) warrants multidisciplinary discussion",
      "Consider patient preferences and comorbidities",
      "Adjuvant hormone therapy with aromatase inhibitor for 5-10 years"
    ],
    "learningOutcomes": [
      "Appropriate use of multigene assays in hormone receptor-positive breast cancer",
      "Integration of patient factors in treatment decision-making",
      "Evidence-based hormone therapy duration recommendations"
    ],
    "guidelineReference": "NCCN Breast Cancer Guidelines V4.2025",
    "difficulty": "Fellow",
    "estimatedTime": 15,
    "tags": [
      "Breast Cancer",
      "Biomarkers",
      "Treatment Planning"
    ],
    "createdAt": "2025-06-30T13:55:42.489Z",
    "isActive": true
  },
  {
    "id": "7b824a09-7e7b-4c43-aa46-e3ab5a13e9dd",
    "topicId": null,
    "title": "58-Year-Old Male with Extensive-Stage Small Cell Lung Cancer",
    "description": "Heavy smoker presenting with cough, weight loss, and multiple liver metastases",
    "patientPresentation": {
      "age": 58,
      "gender": "Male",
      "stage": "T3N2M1 (liver, adrenal)",
      "histology": "Small cell lung cancer",
      "smoking_history": "40 pack-years, current smoker",
      "symptoms": [
        "Persistent cough",
        "15 lb weight loss",
        "Fatigue"
      ],
      "performance_status": "ECOG 1",
      "labs": "Normal LDH, sodium 132 mEq/L"
    },
    "decisionPoints": {
      "options1": [
        "Carboplatin/Etoposide alone",
        "Cisplatin/Etoposide + Atezolizumab",
        "Carboplatin/Etoposide + Atezolizumab",
        "Topotecan monotherapy"
      ],
      "options2": [
        "Ignore if asymptomatic",
        "Check urine osmolality for SIADH",
        "Start immediate sodium replacement",
        "Delay treatment"
      ],
      "question1": "What is the most appropriate first-line treatment regimen?",
      "question2": "How should hyponatremia be evaluated in this patient?"
    },
    "correctPathway": [
      "Carboplatin/Etoposide + Atezolizumab first-line (NCCN Category 1)",
      "Evaluate and treat SIADH if present (common in SCLC)",
      "Continue atezolizumab maintenance after 4 cycles of chemotherapy",
      "Consider prophylactic cranial irradiation after response assessment"
    ],
    "learningOutcomes": [
      "Evidence-based immunotherapy integration in extensive-stage SCLC",
      "Recognition and management of SCLC paraneoplastic syndromes",
      "Appropriate use of maintenance immunotherapy"
    ],
    "guidelineReference": "NCCN Small Cell Lung Cancer Guidelines V4.2025",
    "difficulty": "Resident",
    "estimatedTime": 20,
    "tags": [
      "Lung Cancer",
      "Immunotherapy",
      "Paraneoplastic Syndromes"
    ],
    "createdAt": "2025-06-30T13:55:42.564Z",
    "isActive": true
  },
  {
    "id": "4515b523-abf7-450d-bb3c-b684144d41ff",
    "topicId": null,
    "title": "62-Year-Old Woman with ER+/HER2- Breast Cancer",
    "description": "Post-menopausal woman with T2N1M0 invasive ductal carcinoma",
    "patientPresentation": {
      "age": 62,
      "gender": "Female",
      "stage": "T2N1M0",
      "histology": "Invasive ductal carcinoma",
      "receptors": "ER 95%, PR 85%, HER2 0, Ki-67 25%",
      "comorbidities": [
        "Hypertension",
        "Type 2 diabetes"
      ],
      "performance_status": "ECOG 0"
    },
    "decisionPoints": {
      "options1": [
        "Start chemotherapy immediately",
        "Order Oncotype DX testing",
        "Begin hormone therapy",
        "Refer for radiation therapy"
      ],
      "options2": [
        "Hormone therapy alone",
        "Chemotherapy then hormone therapy",
        "Neoadjuvant chemotherapy",
        "Clinical trial"
      ],
      "question1": "What is the most appropriate next step for treatment planning?",
      "question2": "If Oncotype DX recurrence score is 18, what is the recommended treatment?"
    },
    "correctPathway": [
      "Order Oncotype DX multigene assay (NCCN Category 1)",
      "Intermediate recurrence score (11-25) warrants multidisciplinary discussion",
      "Consider patient preferences and comorbidities",
      "Adjuvant hormone therapy with aromatase inhibitor for 5-10 years"
    ],
    "learningOutcomes": [
      "Appropriate use of multigene assays in hormone receptor-positive breast cancer",
      "Integration of patient factors in treatment decision-making",
      "Evidence-based hormone therapy duration recommendations"
    ],
    "guidelineReference": "NCCN Breast Cancer Guidelines V4.2025",
    "difficulty": "Fellow",
    "estimatedTime": 15,
    "tags": [
      "Breast Cancer",
      "Biomarkers",
      "Treatment Planning"
    ],
    "createdAt": "2025-06-30T13:55:55.063Z",
    "isActive": true
  },
  {
    "id": "df839489-1514-479e-beb4-394b665ab04a",
    "topicId": null,
    "title": "58-Year-Old Male with Extensive-Stage Small Cell Lung Cancer",
    "description": "Heavy smoker presenting with cough, weight loss, and multiple liver metastases",
    "patientPresentation": {
      "age": 58,
      "gender": "Male",
      "stage": "T3N2M1 (liver, adrenal)",
      "histology": "Small cell lung cancer",
      "smoking_history": "40 pack-years, current smoker",
      "symptoms": [
        "Persistent cough",
        "15 lb weight loss",
        "Fatigue"
      ],
      "performance_status": "ECOG 1",
      "labs": "Normal LDH, sodium 132 mEq/L"
    },
    "decisionPoints": {
      "options1": [
        "Carboplatin/Etoposide alone",
        "Cisplatin/Etoposide + Atezolizumab",
        "Carboplatin/Etoposide + Atezolizumab",
        "Topotecan monotherapy"
      ],
      "options2": [
        "Ignore if asymptomatic",
        "Check urine osmolality for SIADH",
        "Start immediate sodium replacement",
        "Delay treatment"
      ],
      "question1": "What is the most appropriate first-line treatment regimen?",
      "question2": "How should hyponatremia be evaluated in this patient?"
    },
    "correctPathway": [
      "Carboplatin/Etoposide + Atezolizumab first-line (NCCN Category 1)",
      "Evaluate and treat SIADH if present (common in SCLC)",
      "Continue atezolizumab maintenance after 4 cycles of chemotherapy",
      "Consider prophylactic cranial irradiation after response assessment"
    ],
    "learningOutcomes": [
      "Evidence-based immunotherapy integration in extensive-stage SCLC",
      "Recognition and management of SCLC paraneoplastic syndromes",
      "Appropriate use of maintenance immunotherapy"
    ],
    "guidelineReference": "NCCN Small Cell Lung Cancer Guidelines V4.2025",
    "difficulty": "Resident",
    "estimatedTime": 20,
    "tags": [
      "Lung Cancer",
      "Immunotherapy",
      "Paraneoplastic Syndromes"
    ],
    "createdAt": "2025-06-30T13:55:55.137Z",
    "isActive": true
  }
]